The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2020

Filed:

Feb. 16, 2016
Applicant:

Shanghai Miracogen Inc, Shanghai, CN;

Inventor:

Chaohong Hu, Shanghai, CN;

Assignee:

SHANGHAI MIRACOGEN INC, Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61P 9/10 (2006.01); C07K 16/28 (2006.01); A61K 38/18 (2006.01); G01N 30/88 (2006.01); G01N 30/02 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6811 (2017.08); A61K 38/1808 (2013.01); A61K 39/0011 (2013.01); A61K 39/001104 (2018.08); A61K 47/6803 (2017.08); A61K 47/6851 (2017.08); A61P 9/10 (2018.01); A61P 35/00 (2018.01); C07K 16/2863 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); G01N 2030/027 (2013.01); G01N 2030/8809 (2013.01);
Abstract

The present invention relates to an antibody-drug conjugate, in particular, to an antibody-drug conjugate targeting an epidermal growth factor receptor. The present invention also relates to a composition comprising the antibody-drug conjugate, and use of the antibody-drug conjugate in manufacture of a medicament for the prophylaxis and/or treatment of a disease associated with epidermal growth factor receptor, in particular in manufacture of a medicament for prophylaxis and/or treatment of colon cancer, rectal cancer, head and neck cancer, lung cancer, ovarian cancer, cervical cancer, bladder cancer and esophageal cancer. The antibody-drug conjugate of the invention has a good inhibition activity on tumor cell growth both in vivo and in vitro, and has low toxicity, and thus has a good application prospect.


Find Patent Forward Citations

Loading…